| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/06/1997 | EP0787136A1 Novel opacity associated proteins, dna encoding the same, and methods of use thereof |
| 08/06/1997 | EP0787015A1 Synthesis of typhoid fever vaccine from a plant or fruit polysaccharide |
| 08/06/1997 | EP0787014A1 Use of flea proteases and protease inhibitors to protect animals from flea infestation |
| 08/06/1997 | EP0787013A1 Human hypoxanthine-(guanine) phosphoribosyl transferase-2 |
| 08/06/1997 | EP0787006A1 Compositions and methods for human gastrointestinal health |
| 08/06/1997 | EP0787003A2 Use of macrophage depleting agents for prolonging the survival of non-autologus hematopoietic cell transplants and animal model assay systems |
| 08/06/1997 | EP0585368B1 Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products |
| 08/06/1997 | EP0548070B1 Monoclonal antibody for differentiation of squamous cell carcinoma antigens and method of use for same |
| 08/05/1997 | US5654407 Human anti-TNF antibodies |
| 08/05/1997 | US5654405 Detection and purification of kgf; treating excessive epithelial cell growth; skin disorders, e.g., psoriasis; antitumor and carcinogenic agents |
| 08/05/1997 | US5654404 Molecule comprising first domain comprising hepatocyte growth factor, second domain comprising activin antagonist or transforming growth factor-beta antagonist |
| 08/05/1997 | US5654403 Immunoglobulins stabilized with a chelator of copper ions |
| 08/05/1997 | US5654277 Inhibiting tumor metastasis in mammals by administering specific tetra- or pentapeptides |
| 08/05/1997 | US5654195 Vectors expressing hybrid viruses, methods of use and novel assays |
| 08/05/1997 | US5654184 Mixing with food transgenic plant which comprises and expresses dna sequence coding for antigen or antigenic determinant of pathogenic microorganism capable of eliciting immune response on oral administration |
| 08/05/1997 | US5654174 Herpes simplex virus glycoprotein D variants |
| 08/05/1997 | US5654145 Trophinin and trophinin-assisting nucleic acids and methods of detection thereof |
| 08/05/1997 | US5654136 Polypeptide |
| 08/05/1997 | US5653985 Purified gp120 composition retaining natural conformation |
| 08/05/1997 | US5653981 Use of nigella sativa to increase immune function |
| 08/05/1997 | US5653980 For immunoglobulin e mediated allergies |
| 08/05/1997 | US5653977 Anti-idiotypic antibody that mimics the GD2 antigen |
| 08/05/1997 | US5653976 Recombinant varicella-zoster virus and process for constructing same |
| 08/05/1997 | CA1339240C Synthetic vaccine against aids virus |
| 08/05/1997 | CA1339204C Mucin core polypeptide, antibodies and probes |
| 08/05/1997 | CA1339202C Method for preparing monoclonal antibody to hepatitis b surface antigen |
| 08/05/1997 | CA1339201C Chimera monoclonal antibody and a production process thereof |
| 08/05/1997 | CA1339199C Magnetic protein conjugates, a process for the preparation thereof, and the use thereof |
| 08/05/1997 | CA1339198C Antibodies to the antigen campath-1 |
| 07/31/1997 | WO1997027485A1 Method for detecting anti-gadii antibody and method for diagnosing cancer using said detection method |
| 07/31/1997 | WO1997027311A1 Mixture of recombinant vaccinia vectors as polyenv vaccines for hiv |
| 07/31/1997 | WO1997027302A1 Vaccine prepared using human-origin hantaan virus nucleocapsid protein expressed from escherichia coli |
| 07/31/1997 | WO1997027301A1 Decorin binding protein compositions and methods of use |
| 07/31/1997 | WO1997027300A1 TOXOPLASMA GONDII ANTIGEN Tg20 |
| 07/31/1997 | WO1997027299A1 Mammalian cx3c chemokine genes |
| 07/31/1997 | WO1997027298A1 Biologically active and particularly peptide molecules having a potentiating effect on growth hormone biological activity |
| 07/31/1997 | WO1997027296A1 Nucleic acids and proteins related to alzheimer's disease, and uses therefor |
| 07/31/1997 | WO1997027288A1 New attenuated strain of the virus causing the porcine reproductive respiratory syndrome (prrs), vaccines and diagnostic means obtainable with said strain, and production process |
| 07/31/1997 | WO1997027218A1 Method for evaluating and affecting male fertility |
| 07/31/1997 | WO1997027216A1 Amplification of response from expressed recombinant protein |
| 07/31/1997 | WO1997027215A1 Nucleotide and amino acid sequences of t. pallidum rare outer membrane protein |
| 07/31/1997 | WO1997027208A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 07/31/1997 | WO1997026914A1 Methods and compositions for passive immunotherapy |
| 07/31/1997 | WO1997026912A2 Anti-cd18 antibodies for use against stroke |
| 07/31/1997 | WO1997026911A1 Malaria vaccine based upon the addition of a msa1 peptide |
| 07/31/1997 | WO1997026910A2 Tumour vaccine for immunotherapy of malignant tumours |
| 07/31/1997 | WO1997026883A1 Modulation of th1/th2 cytokine expression by ribavirin® and ribavirin® analogs in activated t-lymphocytes |
| 07/31/1997 | WO1997026853A2 Dna encoding galanin galr2 receptors and uses thereof |
| 07/31/1997 | WO1997026784A1 Induction of immune response against desired determinants |
| 07/31/1997 | WO1997018790A3 Therapeutic and diagnostic agents for the treatment of microbial infections |
| 07/31/1997 | DE19602985A1 Tumour vaccine for treatment of, e.g., carcinoma melanoma or leukaemia |
| 07/31/1997 | CA2245002A1 Malaria vaccine based upon the addition of a msa1 peptide |
| 07/31/1997 | CA2244881A1 Amplification of response from expressed recombinant protein |
| 07/31/1997 | CA2244412A1 Nucleic acids and proteins related to alzheimer's disease, and uses therefor |
| 07/31/1997 | CA2244373A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 07/31/1997 | CA2244147A1 Decorin binding protein compositions and methods of use |
| 07/31/1997 | CA2243557A1 Methods and compositions for passive immunotherapy |
| 07/31/1997 | CA2242200A1 Toxoplasma gondii antigen tg20 |
| 07/31/1997 | CA2216436A1 New attenuated strain of the virus causing the porcine reproductive and respiratory syndrome (prrs), vaccines and diagnostic kits derived from the same, and procedures for the obtaining of the same |
| 07/31/1997 | CA2216227A1 Dna encoding galanin galr2 receptors and uses thereof |
| 07/31/1997 | CA2196238A1 Homogeneous isolate of urabe mumps virus and vaccines containing the isolate |
| 07/30/1997 | EP0786521A1 Nucleic acid encoding PspA |
| 07/30/1997 | EP0786519A2 Staphylococcus aureus polynucleotides and sequences |
| 07/30/1997 | EP0786518A1 Streptococcus equi vaccine |
| 07/30/1997 | EP0786472A1 Vaccines and diagnostic assays for Haemophilus influenzae |
| 07/30/1997 | EP0786255A1 Methods of improving allograft or xenograft tolerance by administration of an LFA-3 or CD2 binding protein |
| 07/30/1997 | EP0786088A2 Presentation of hydrophobic antigens to t-cells by cd1 molecules |
| 07/30/1997 | EP0786083A1 Diagnosis and monitoring process, and medicaments for the therapy of states of shock in human beings |
| 07/30/1997 | EP0786010A1 Cell-type specific gene transfer using retroviral vectors containing antibody-envelope and wild-type envelope-fusion proteins |
| 07/30/1997 | EP0786004A1 Cloning, expression and characterisation of a novel form of phosphatidylinositol-3-kinase |
| 07/30/1997 | EP0785997A2 Delivery system |
| 07/30/1997 | EP0785990A1 Method for stimulating profileration of colon cells using pomc 76-103 |
| 07/30/1997 | EP0785800A1 PROBIOTIC FOR CONTROL OF $i(SALMONELLA) |
| 07/30/1997 | EP0785713A1 Creating an aerosolized formulation of insulin |
| 07/30/1997 | CN1155904A LAG-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody |
| 07/30/1997 | CN1155843A Composition for inducing a mucosal imune response |
| 07/29/1997 | US5652361 Macrocyclic ligands and complexes |
| 07/29/1997 | US5652342 Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same |
| 07/29/1997 | US5652338 Neutrophil chemotactic factor |
| 07/29/1997 | US5652223 DNA encoding CAI resistance proteins and uses thereof |
| 07/29/1997 | US5652217 Nucleotide sequence from staphylococcus aureus which codes for protein or polypeptide |
| 07/29/1997 | US5652210 Soluble splice variant of the Fas (APO-1) antigen, FasΔTM |
| 07/29/1997 | US5652138 Immunoreacts with human immunodeficiency virus glycoprotein |
| 07/29/1997 | US5652122 Nucleic acids encoding and methods of making tat-derived transport polypeptides |
| 07/29/1997 | US5652119 Recombinant feline herpesvirus vaccine |
| 07/29/1997 | US5652113 Contacting nonneuronal cells expressing on their cell surface the human serotonin receptor with chemical compound under conditions suitable for binding, detecting specific binding of compound to receptor |
| 07/29/1997 | US5652095 Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity |
| 07/29/1997 | US5651993 Irradiating leukocyte mixture in psoralen presence; reacting with peptide antigens |
| 07/29/1997 | US5651986 Controlled local delivery of chemotherapeutic agents for treating solid tumors |
| 07/29/1997 | US5651972 Use of recombinant swine poxvirus as a live vaccine vector |
| 07/29/1997 | US5651971 Producing immunogenic constructs using soluble carbohydrates activated via organic cyanylating reagents |
| 07/29/1997 | US5651968 Methods and compositions for attenuating antibody-mediated xenograft rejection in human recipients |
| 07/29/1997 | CA1339188C Removal of protein a from antibody preparations |
| 07/29/1997 | CA1339187C Bacterial antigens, antibodies, vaccines, and methods of manufacture |
| 07/29/1997 | CA1339098C Characterization and detection of sequences associated with autoimmune diseases |
| 07/29/1997 | CA1339068C High molecular weight cell-associated protein of campylobacter pylori |
| 07/24/1997 | WO1997026538A1 Allele-specific peptide epitope strategy for vaccine development |
| 07/24/1997 | WO1997026535A1 Isolated tyrosinase derived peptides and uses thereof |
| 07/24/1997 | WO1997026373A1 Isolation and propagation of a human herpesvirus derived from aids-associated kaposi's sarcoma cells |
| 07/24/1997 | WO1997026359A1 System for the expression of heterologous antigens as fusion proteins |